Chewable tablets, as a special type of oral solid dosage form, are widely used in the treatment of children, the elderly, and patients with swallowing difficulties due to their convenient administration, pleasant taste, and high patient compliance. However, their quality control involves multi-dimensional technical requirements, necessitating strict control from raw materials and processes to the finished product to ensure safety and efficacy.
Raw material and formulation control are fundamental. The raw materials for chewable tablets must meet pharmaceutical standards. The crystal form, particle size, and flowability of the active ingredient directly affect mixing uniformity and disintegration performance. The selection of excipients is particularly critical. For example, fillers (microcrystalline cellulose, mannitol) must balance compressibility and palatability, and the ratio of flavoring agents (aspartan, stevia) and lubricants (magnesium stearate) needs to be optimized experimentally to avoid excessive amounts affecting disintegration time.
Standardization of the manufacturing process is the core. The tableting process requires controlled pressure range (typically 15-30 kN) to ensure moderate tablet hardness (5-15 kg/cm²), guaranteeing both transport stability and rapid disintegration during chewing. The choice between wet granulation and direct compression should be based on material characteristics, and the drying temperature must not exceed the heat-sensitive threshold of the active ingredient. Furthermore, the production environment must comply with GMP requirements to prevent cross-contamination and microbial growth.
A comprehensive quality control system is essential. Physical property testing includes tablet weight variation (±5%), hardness, friability, and disintegration time (typically ≤30 minutes). Chemical testing focuses on content uniformity (±7.5%) and dissolution (compliant with pharmacopoeia requirements). Microbiological limit testing (total bacterial count ≤1000 CFU/g, mold ≤100 CFU/g) and heavy metal residues (e.g., lead ≤10 ppm) are also crucial.
Stability studies are essential for long-term quality assurance. Accelerated testing (40℃/75%RH) and long-term storage (25℃/60%RH) require monitoring for changes in appearance, hardness reduction, and degradation of active ingredients. Content stability should be verified using HPLC or UV methods to ensure controllable quality throughout the shelf life.
In summary, quality control of chewable tablets requires integrating scientific formulation design, meticulous production, and rigorous testing. Through multi-stage collaborative management, the ultimate goal is to achieve a balance between safety, efficacy, and patient experience.
